Checkpoint Immunotherapy for Melanoma and Advanced Cancer: Current and Novel Targets

Jason Luke

Jason Luke
Assistant Professor of Medicine

A medical oncologist, Jason Luke, MD, FACP, cares for patients with melanoma and advanced solid tumors. In the context of a multidisciplinary team of doctors and nurses, Dr. Luke works to bring a personalized approach to each patient through a comprehensive, compassionate and individualized care plan that is at the forefront of medicine. Dr. Luke's research focuses on translational therapeutic advances for melanoma and early phase drug development, particularly immunotherapy. ... View full profile

More Information

What kind of information would you like to request?     More Information       Make a Referral

Leave this field empty

Dr. Jason Luke, assistant professor of medicine, explains the basic aspects as well as biomarkers of an effective antitumor immune response and reviews data from completed immunotherapy trials for melanoma and advanced cancers.  Dr. Luke also outlines novel drug targets and rational combination immunotherapy strategies

Comments